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The purpose of this work was to analyze cDNA encoding human monocyte chemoattractant protein-l (MCP-I), pre- 
viously isolated from glioma cell line culture fluid. Screening of a cDNA library from total poly(A) RNA of glioma cell 
line U-105MG yielded a clone that coded for the entire MCP-1. Nucleotide sequence analysis and comparison with the 
amino acid sequence of purified MCP-1 showed that the cDNA clone comprises a 53-nucleotide 5’-non-coding region, 
an open reading frame coding for a 99-residue protein of which the last 76 residues correspond exactly to pure MCP-1, 
and a 389nucleotide 3’-untranslated region. The hydrophobicity of the first 23 residues is typical of a signal peptide. 
Southern blot analysis of human and animal genomic DNA showed that there is a single MCP-1 gene, which is conserved 
in several primates. MCP-1 mRNA was induced in human peripheral blood mononuclear leukocytes (PBMNLs) by PHA, 
LPS and IL-l, but not by IL-2, TNF, or IFN-y. Among proteins with similar sequences, the coding regions of MCP-1 
and mouse JE show 68% identity. This suggests that MCP-1 is the human homologue of the mouse competence gene 
JE. 
Inflammation; Chemotaxis; Macrophage infiltration 
1. INTRODUCTION 
Macrophages participate in the initial reaction to 
tissue injury, which includes not only antigen pro- 
cessing and presentation, but also secretion of fac- 
tors that mediate systemic host defense responses 
and local inflammation [l]. They originate from 
blood monocytes, which leave the circulation in 
response to several signals that are thought to in- 
elude chemoattractants produced at the inflam- 
matory focus. Our objective has been to isolate 
and characterize monocyte chemoattractants in 
order to evaluate their significance as mediators of 
inflammation. 
We recently purified to homogeneity two human 
Correspondence address: T. Yoshimura, Laboratory of Im- 
munobiology, Bldg 560, Rm 12-71, NCI-FCRF, Frederick, MD 
21701, USA 
monocyte chemoattractants from the culture fluid 
of a glioma cell line. Although these two attrac- 
tants could be separated into two peaks by cation- 
exchange HPLC, their amino acid compositions 
Abbreviations: CSF, colony-stimulating factor; CTAP, connec- 
tive tissue activating peptide; IFN, interferon; IL-l, 
interleukin-1; LPS, lipopolysaccharide; MCP-1, monocyte 
chemoattractant protein-l; PBMNL, peripheral blood 
mononuclear leukocyte; PDGF, platelet-derived growth factor; 
PHA, phytohemagglutinin; TNF, tumor necrosis factor 
were identical [2]. Likewise, two cation-exchange 
HPLC peaks of monocyte chemotactic activity, 
purified from culture fluid of PHA-stimulated 
human blood lymphocytes, were identical in amino 
acid composition to one another and to the glioma- 
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A. SP-4: NHz-Met-Asp-His-Leu-Asp-Lys-Gin-Thr-Gin-COOH 
CICCACAA 
B. SP-4-A: 5’-GT TG GT TG T7 TC AA TG TCCAT-3’ 
TCTTGTGG 
CICCAIAA 
SP-4-B: 5’-GT TG GT TG Tl TC AG TG TCCAT-3’ 
TCTTGCGG 
C. 
+ Coding Region --_I 
- 
I 
100 
Fig.1. (A) Amino acid sequence of a portion of a peptide 
fragment of an S. aureus V8 protease digest of MCP-1. (B) 
Probes based on the above sequence. (C) Structural 
organization and sequencing strategy of human MCP-I cDNA. 
Arrows show direction and extent of determined sequences. 
Cross-hatched area indicates the coding region for the mature 
form of MCP-1. Dotted region indicates poly(A). 
derived proteins [3]. The complete amino acid se- 
quence of one of the monocyte chemoattractants 
purified from glioma culture fluid was determined 
on a set of partial digests by a combination of Ed- 
man degradation and mass spectrometry. A single 
protein chain with a blocked N-terminus 
(pyroglutamic acid) and a total of 76 residues were 
identified [4]. In this and future communications, 
it will be named monocyte chemoattractant 
protein-l (MCP-1). We now report the cloning of 
MCP-1 full-length cDNA, its hybridization to 
genomic DNA from other species, and detection of 
MCP-1 mRNA in normal cells stimulated by 
mediators of inflammation. 
2. MATERIALS AND METHODS 
Restriction enzymes, DNA modifying enzymes, and reagents 
for cDNA preparation were from Bethesda Research 
Laboratories (Bethesda, MD). DNA sequencing reagents were 
from US Biochemicals. Radiochemicals were from Amersham 
-50 -40 -30 -20 -10 -1 
CTAACCCAGAAACATCCAATCTCAAACTGAAGCTCGCACTCTCGCCTCCAGC 
10 20 M 40 50 50 
ATG AAA GTC TCT GCC GCC ClT CTG TGC CTG CTG CTC ATA GCA GCC ACC I-K ATT CCC CAA 
Met Lys Vai Ser Ala Ala Leu Leu Cys Leu Leu Leu Iie Ala Ala Thr Phe Ile Pro Gin 
70 80 90 100 110 120 
GCG CTC GCT CAG CCA GAT GCA ATC AAT GCC CCA GTC ACC TGC TGT TAT AAC l-K ACC AAT 
Giy Leu Ala Gin Pro Asp Ala Ile Asn Ala Pro Vai Thr Cys Cys Tyr Asn Phe Thr Asn 
A ------- 
130 140 150 160 170 130 
AGG AAG ATC TCA GTG CAG AGG CTC GCG AGC TAT AGA AGA ATC ACC AGC AGC AAG TGT CCC 
Arg Lys Ile Ser Vai Gin Arg Leu Ala Ser Tyr Arg Arg Ile Thr Ser Ser Lys Cys Pro 
190 200 210 220 230 240 
AAA GAA GCT GTG ATC TTC AAG ACC Al-T GTG GCC AAG GAG ATC TGT GCT GAC CCC AAG CAG 
Lys Giu Ala Val Iie Phe Lys Thr Ile Vai Ala Lys Giu Iie Cys Ala Asp Pro Lys Gln 
250 290 270 290 290 300 
AAG TGG G-l-r CAG GAT TCC ATG GAC CAC CTG GAC AAG CAA ACC CAA ACT CC0 AAG ACT TGA 
Lys Trp Val Gin Asp Ser Met Asp His Leu Asp Lys Gin Thr Gin Thr Pro Lys Thr 
310 320 330 340 350 390 370 39 
ACACTCACTCCACAACCCAAGAATCTGCAGCTAACTTATTTATT 
0 390 400 410 420 430 440 450 4 
ATAATGAAmTGmGTTGATGTGAAACArrATGCCTTAAGTAATGTTAA~C~A~AAGTTA~GATG~TAAG 
50 470 490 490 500 510 520 530 
TTTATCTTTCATGGTACTAGTGl-ilTTT AGATACAGAGACTTGGGGAAATTGCTTfTCCTCTTGAACCACAGTTCTACC 
540 550 550 570 590 590 500 610 
CCTGGGATGTTTTGAGGGTCTTTGCAAGAATCATTAATACAAAGAA- AACATTCCAATGCATTGCTAAAATA 
620 630 940 650 990 670 990 
TTATTGTGGAAATGAATAmTGTAACTATTACACACCAAATAAATATA~GTACAAAAAAAAAAAAAA . . . . . . . . . 
Fig.2. Nucleotide sequence of human MCP-1. Triangle: N-terminus of mature MCP-1. Dashed line: potential N-linked glYcosYlation 
site. Solid line: oligonucleotide probe sequence. Dotted line: polyadenylation signal WI. 
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or New England Nuclear. h ZAP II vector was from Stratagene 
(La Jolla, CA). Cytokines were from Boehringer Mannheim. 
Total RNA was isolated from glioma cell line U-105MG by 
the guanidinium isothiocyanate method; poly(A) RNA was 
isolated by oligo(dT)-cellulose chromatography IS]. cDNA syn- 
thesized by a modification of the method of Gubler and Hoff- 
man [6] was used to prepare a library in h ZAP II vector [7]. 
Qligodeoxynucleotides were synthesized by the phosphorami- 
dite method [8] and purified by HPLC. Probes (fig.lB) were 
synthesized on the basis of the sequence of a peptide fragment 
(SP-4, fig.lA) generated by digestion of MCP-1 with S. aureus 
VI3 protease [4]. Approx. 5 x 10s recombinant phage from the 
cDNA library were screened by high-density plaque hybridiza- 
tion [5,9] with a mixture of “P-labeled oligonucleotides SP4-A 
and SP-4-B. Hybridization to nitrocellulose filters was, carried 
out overnight at 45°C in a solution containing 6 x standard 
saline citrate (SSC), 5 x Denhardt’s solution, 0.05% sodium 
pyrophosphate, 1% SDS, 100 @g/ml heat-denatured, sheared, 
salmon sperm DNA and 1 x lo6 dpm/ml probe. Filters were 
washed once with 6 x SSC, 0.1% SDS at 45°C for 5 min, three 
times at 35°C for 30 min, and were dried and exposed overnight 
to XS-5 film (Kodak) with an intensifying screen at -80°C. 
Phagemids carried within A ZAP II recombinants were rescued 
with helper phage [7]. cDNA inserts were subcloned into 
M13mp19 [lo] and single strands were sequenced on field gra- 
dient gels [ll] by the dideoxynucleoside triphosphate chain- 
termination method [12]. Sequence data were compiled and 
analyzed with computer assistance [13]. 
Human PBMNLs were stimulated with 2.5 fig/ml of PHA, 
10 /cg/ml LPS, or 100 U/ml of the following human recombi- 
nant LPS-free cytokines: IL-lj3, IL-2, TNFa, IFN-7. Northern 
blot analysis of poly(A) RNA was performed by the glyoxal- 
dimethyl sulfoxide method [5] in a 1% agarose gel with a probe 
of MCP-1 cDNA insert labeled with [c~-“‘P]CTP by random 
priming [14]. Filters were hybridized at 42°C overnight in 50% 
formamide, 1 M NaCl, 5 x Denhardt’s olution, 1 mM EDTA, 
0.1% sarkosyl, 100 @g/ml sheared-denatured salmon sperm 
DNA, 1 x lo6 dpm/ml probe and 50 mM piperazine- 
N,N’-bis(2-ethanesulfonic acid), pH 7. Filters were washed 
twice with 2 x SSC, 0.1% SDS at 37°C for 30 min and 0.1 x 
SSC, 0.1% SDS at 50°C for 30 min prior to autoradiographic 
exposure. 
Southern blot analysis was performed as described [5] in a 
1% agarose gel with 10 ,ug restriction-enzyme-cleaved DNA per 
lane. Hybridization was as described for library screening ex- 
cept that transfers were made to nylon filters, hybridization 
temperature was 65°C and the probe was “P-labeled MCP-1 
cDNA. Filters were washed once in the hybridization solution 
used for library screening at 65°C for 1 h, then twice in 0.1 x 
SSC, 0.1% SDS at 48OC for 30 min. 
3. RESULTS 
A cDNA library was constructed with poly(A) 
RNA from the human glioma cell line (U-IOSMG) 
in cloning vector h ZAP II. Approx. 5 x lo5 
recombinant phage were screened with the 
oligonucleotide probes shown in fig.lB. 48 positive 
signals on duplicate filters were obtained (-0.01% 
abundance). 15 clones were plaque purified and 
phagemid DNA was prepared. By preliminary 
nucleotide sequence analysis, at least three clones 
coded for MCP-1. The insert from the clone with 
the longest 5 ’ -untranslated region was sequenced 
(figs lC,2). 
Based on the amino acid sequence of pure 
MCP-1 [4], the mature form of the protein starts 
with glutamine at residue 24 (nucleotide 70). The 
amino acid sequence deduced from nucleotides 70 
to 297 is identical to the directly determined 
76-residue sequence of pure MCP-1 [4]. The cDNA 
sequence contains an in-frame methionine triplet 
69 nucleotides upstream from the triplet cor- 
responding to the NHz-terminus of MCP-1. Seven 
Fig.3. Expression of MCP-1 mRNA in tumor cell lines. 5 /cg 
poly(A) mRNA from each cell line were used. The first 5 blots 
are from glioma lines. SK-RC29, UMRC 2: renal cell 
carcinomas. HOS: osteosarcoma. GCT: fibrous histiocytoma. 
HL60, U937, Raji, Jurkat, H9: leukemia or lymphoma cell 
lines. 
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of the 9 residues in the methionine triplet region, 
CCAGCATGA, match the sequence believed to be 
optimal for translation initiation [15]. The length 
and hydrophobic character of the deduced amino 
acid sequence from the methionine to the 
NHz-terminus of MCP-1 are typical of a signal 
Fig.4. Induction of MCP-1 mRNA in human PBMNLs by 
mitogens or huma:. recombinant cytokines. (A) PBMNLs were 
cultured with 2.5 pg/ml PHA or lOpg/ml LPS, and mRNA 
was extracted at the indicated times. (B) Cells were cultured 
with 100 U/ml of each cytokine for 6 h; then mRNA was 
extracted. 
peptide [ 161. There is a single consensus equence 
for N-linked glycosylation targeting amino acid 38. 
The A + T content of the 3 ’ -untranslated region 
(66%) is not nearly as high as that found in some 
transiently expressed mRNAs [17]. Unlike a 
number of genes encoding proteins related to the 
inflammatory response [ 181, there is no S-nucleo- 
tide sequence, TTATTTAT, in the 3 ‘-untranslated 
region. 
In a survey of 5 different glioma cell lines, we 
reported that all released chemotactic activity for 
human monocytes [20]. It was therefore of interest 
to probe these and other tumor cell lines for 
MCP-1 mRNA message. Fig.3 shows Northern 
blots with a cDNA probe for MCP-1. The high and 
low mRNA, respectively, of gliomas U-105MG 
and KMG-5 correlates with previously observed 
Fig.5. Southern blotting analysis of human genomic DNA 
digested with various endonucleases. (A) EcoRI, (B) BumHI, 
(C) &I, (D) NindIII. 
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Fig.6. Hybridization of MCP-1 cDNA with genomic DNA from 
various species. 
levels of chemotactic activity produced by these 
two lines [20]. MCP-1 mRNA was not detected in 
other human tumor cell lines. 
Since PBMNL-derived MCP-1 was indistinguish- 
able from glioma-derived MCP-1, we carried out 
Northern blot analyses of mRNA from PBMNLs 
stimulated with PHA. No mRNA was detected 
before stimulation, but high levels of mRNA were 
MCP-1 
RANTES 
pLD78 
TCA 3 
JE 
MIP 
MCP-1 
RANTES 
pLD78 
TCA 3 
JE 
MIP 
detected 3 and 6 h after addition of PHA (fig.4A). 
10 pg/ml of LPS also induced high mRNA levels 
in these cells. IL-lp induced MCP-1 mRNA, 
though the level was less than for PHA (fig.4B). 
Induction of MCP-1 mRNA by IL-2, TNFcu, or 
IFN-y was not detected. 
To identify genomic DNA fragments carrying 
the gene for MCP-1, human DNA restriction en- 
donuclease digests were subjected to Southern blot 
analysis (fig.5). After BarnHI or Hind111 diges- 
tion, a single band was seen. PstI digestion gave 2 
major bands, which is in agreement with the fact 
that there is a PstI restriction site in the MCP-1 
cDNA. The data show that there is a single MCP-1 
gene. DNA from different species was digested 
with EcoRI and hybridized to the same probe 
(fig.6). Under conditions of high stringency, 
hybridization occurred with DNA of chimpanzee, 
baboon and capuchin, but not of other species. 
Proteins with amino acid sequences imilar to 
that of MCP-1 are shown in fig.7. Among the 5 
proteins, 4 are known only by the nucleotide se- 
quence of cDNAs cloned from mRNA that in- 
creased in response to mitogenic stimuli. All 5 have 
4 half-cystine residues in the same location, and 
the first 2 half-cystines are adjacent. Sequence 
similarity to MCP-1 is greatest for mouse JE (42 of 
76 residues). Comparison of the sequences of 
mouse JE and human MCP-1 cDNAs shows that 
68% of the nucleotides of the coding region are 
matched. 
SPYSSDT 
40 50 60 70 
AVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT 
AVVFVTRKNRQVCANPEKKWVREYINSLEMS 
GVIFLTKRSRQVCADPSEEWVQKYVSDLELSA 
Q 
AVVFRLNKGRESCASTNKTWVQ NHLKKVNPC 
AVVFVTKLKREV ADPKKEWVQTYIKNLDRNQMRSEP--- 
GVIFLTKRNRQI ADSKETWVQEYITDLELNA 
Fig.7. Amino acid sequence of proteins similar to MCP-1. RANTES: deduced from cDNA cloned from antigen or mitogen-stimulated 
human T cell lines [21]. pLD78: from stimulated human tonsillar lymphocytes [22]. TCA 3: from ConA-stimulated mouse T cell line 
[23]. JE: from platelet-derived growth factor (PDGF)-stimulated mouse fibroblast line [24]. MIP: from culture fluid of LPS-stimulated 
mouse macrophage cell line [25,26]. 
491 
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4. DISCUSSION 
In view of the fact that MCP-1s from glioma 
cells and mitogen-stimulated PBMNLs are in- 
distinguishable, either glioma cells or stimulated 
PBMNLs could provide mRNA for cDNA library 
construction. We selected the glioma cell line, since 
it produced the attractant constitutively. The 
cDNA clone derived from the glioma cell library 
detected mRNA in both glioma cells and PHA- 
stimulated PBMNLs. This is consistent with the 
observation that the amino acid compositions of 
MCP-1s from the two sources are identical [2,3]. 
Although MCP-1 mRNA was detected in several 
glioma cell lines, no message was found in 9 cell 
lines representing other types of tumors. Thus, ex- 
pression of the MCP-1 gene is not a property of all 
neoplastic cells. 
The amino acid composition of a monocyte 
chemoattractant produced by aortic smooth mus- 
cle cells of the baboon [27] is identical to that of 
MCP-1 [3]. Hybridization of the MCP-1 cDNA 
probe with baboon DNA (fig.6) is added evidence 
for the relationship between MCP-1 and the 
smooth muscle product, and indicates that both 
lymphocytes and vascular smooth muscle cells can 
produce this attractant. Penetration of vascular 
endothelium by blood monocytes occurs in ex- 
perimental atherosclerosis [28]. Since local produc- 
tion of MCP-1 could mediate accumulation of 
monocytes in the lesions, it will be of interest to 
determine by in situ hybridization if MCP-1 
mRNA is detectable in endothelium or smooth 
muscle in the early stages of atherosclerosis. 
In contrast to MCP-1, which does not attract 
neutrophils, a protein attractant for neutrophils 
Table 1 
Cellular expression of MCP-1 or JE mRNA 
Cell Species Stimulus Reference 
Lymphocyte human PHA, IL-l This work, 
I301 
Macrophage mouse LPS, Listeria [311 
Fibroblast mouse PDGF, IL-l, VSV, 
POlY(I) : POlY(C) 124,321 
Endothelium rat EGF I331 
Smooth muscle baboon (-) [271 
VSV, vesicular stomatitis virus; poly(1) :poly(C), double- 
stranded RNA; EGF, epidermal growth factor 
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has been described [29], which has sequence 
similarity to several host defense cytokines. 
Members of this group contain 4 half-cystine 
residues, the positions of which are identical. The 
first two cysteines are separated by a single amino 
acid (C-X-C). As shown in fig.7, MCP-1 is part of 
another group of proteins with 4 half-cystine 
residues. In contrast to the C-X-C group, the first 
2 half-cystines are adjacent (C-C). The C-C group 
does not have sequence similarity to the C-X-C 
group. Like members of the C-X-C group, MIP 
and MCP-1 have inflammatory properties. The se- 
quences of the other C-C proteins were deduced 
from mRNAs that increase in response to 
mitogenic stimuli; although they are without 
known function, they all have signal peptide se- 
quences, suggesting that they are secreted pro- 
ducts. The protein with the greatest sequence 
similarity to MCP-1 is mouse JE (68% nucleotide 
similarity in the coding sequence of the cDNAs). 
This high degree of similarity suggests that MCP-1 
is the human homologue of mouse JE. If we 
assume identity of MCP-1 with the JE product, 
which is a cell-cycle competence protein, then 
many mitogenic and activation stimuli may cause 
secretion of MCP-1 by a wide variety of cells (table 
1). Thus, the potential biological role of MCP-1 is 
not limited to recruitment of blood monocytes in 
cellular immune reactions [3]. The increased JE 
mRNA associated with LPS activation of 
macrophages [31] suggests that generation of ac- 
tivated macrophages is accompanied by a signal 
for accumulation of more effector cells at the site. 
Moreover, the generation of JE/MCP-1 mRNA by 
mitogenic stimuli emphasizes that both prolifera- 
tion (for wound healing) and cell recruitment (for 
host defense) are part of the response to tissue 
injury. 
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